284 related articles for article (PubMed ID: 11330968)
1. Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature.
Jeyakumar A; Cabeza R; Hindenburg A
Gynecol Oncol; 2001 May; 81(2):314-7. PubMed ID: 11330968
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
[TBL] [Abstract][Full Text] [Related]
3. Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary.
Kasenda B; Harter P; Hirsch T; Ast A; Buhrmann C; Glaser F; Du Bois A
Acta Obstet Gynecol Scand; 2009; 88(11):1288-90. PubMed ID: 19900144
[TBL] [Abstract][Full Text] [Related]
4. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
6. Advanced-stage small cell carcinoma of the ovary in pregnancy: long-term survival after surgical debulking and multiagent chemotherapy.
Tewari K; Brewer C; Cappuccini F; Macri C; Rogers LW; Berman ML
Gynecol Oncol; 1997 Sep; 66(3):531-4. PubMed ID: 9299272
[TBL] [Abstract][Full Text] [Related]
7. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Dimopoulos MA; Papadimitriou C; Hamilos G; Efstathiou E; Vlahos G; Rodolakis A; Aravantinos G; Kalofonos H; Kouroussis C; Gika D; Skarlos D; Bamias A
Gynecol Oncol; 2004 Dec; 95(3):695-700. PubMed ID: 15581984
[TBL] [Abstract][Full Text] [Related]
8. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
10. [Medical treatment of ovarian malignant germ cell tumors in the adult].
Culine S; Lhommé C; Droz JP
Bull Cancer; 1997 Sep; 84(9):919-21. PubMed ID: 9435816
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
Hong W; Zhang R; Liu L
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
[TBL] [Abstract][Full Text] [Related]
13. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review.
Karimi Zarchi M; Behtash N; Modares Gilani M
Arch Gynecol Obstet; 2008 Jan; 277(1):75-8. PubMed ID: 17653741
[TBL] [Abstract][Full Text] [Related]
14. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy].
Ishibashi M; Nakayama K; Oride A; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2009 Mar; 36(3):513-7. PubMed ID: 19295284
[TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recurrent and persistent germ cell tumors with cisplatin, vinblastine, and bleomycin.
Jacobs AJ; Harris M; Deppe G; DasGupta I; Cohen CJ
Obstet Gynecol; 1982 Jan; 59(1):129-32. PubMed ID: 6176923
[TBL] [Abstract][Full Text] [Related]
17. Late relapse of ovarian dysgerminoma: case report and literature review.
Bekaii-Saab T; Einhorn LH; Williams SD
Gynecol Oncol; 1999 Jan; 72(1):111-2. PubMed ID: 9889041
[TBL] [Abstract][Full Text] [Related]
18. Medical treatment of epithelial ovarian cancer.
González-Martín AJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1125-43. PubMed ID: 15606338
[TBL] [Abstract][Full Text] [Related]
19. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
[TBL] [Abstract][Full Text] [Related]
20. Primary angiosarcoma of the ovary: a case report of Stage I disease.
Quesenberry CD; Li C; Chen AH; Zweizig SL; Ball HG
Gynecol Oncol; 2005 Oct; 99(1):218-21. PubMed ID: 16081151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
